Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model

Medullary thyroid carcinoma (MTC) is a tumor deriving from the thyroid C cells. Vandetanib (VAN) and cabozantinib (CAB) are two tyrosine kinase inhibitors targeting REarranged during Transfection (RET) and other kinase receptors and are approved for the treatment of advanced MTC. We aim to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales: Carra, Silvia, Gaudenzi, Germano, Dicitore, Alessandra, Saronni, Davide, Cantone, Maria Celeste, Plebani, Alice, Ghilardi, Anna, Borghi, Maria Orietta, Hofland, Leo J., Persani, Luca, Vitale, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002338/
https://www.ncbi.nlm.nih.gov/pubmed/33809722
http://dx.doi.org/10.3390/ijms22063031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002338/
https://www.ncbi.nlm.nih.gov/pubmed/33809722
http://dx.doi.org/10.3390/ijms22063031

Ejemplares similares